HDFC Pharma And Healthcare Fund Direct-Growth
Equity: Sectoral-Pharma - Growth (Open ended)
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: BSE Healthcare Total Return IndexCheck Portfolio Overlap →
NAV: ₹20.8-0.11%
22 Oct 2026
Rolling Returns Analysis
Rolling annualized returns of HDFC Pharma And Healthcare Fund Direct-Growth across 1Y, 3Y and 5Y windows — average, best, worst returns and percentage of positive return periods.
| Metric | 1 Yr Rolling Returns | 3 Yr Rolling Returns | 5 Yr Rolling Returns | 7 Yr Rolling Returns |
|---|---|---|---|---|
| Analysis period | 14 Oct, 2024 - 22 Oct, 2026 | 22 Oct, 2026 - 22 Oct, 2026 | - | - |
| Average returns | 24.74% | 27.84% | - | - |
| Standard deviation | 15.67% | - | - | - |
| Best returns | 70.12% 1 year ending on 06 Nov, 2024 | 27.84% 3 years ending on 22 Oct, 2026 | - | - |
| Worst returns | 1.55% 1 year ending on 12 Jan, 2026 | 27.84% 3 years ending on 22 Oct, 2026 | - | - |
| Period with positive return | 100.00% | 100.00% | - | - |
| Period with return > 5% | 94.80% | 100.00% | - | - |
| Period with return > 10% | 80.00% | 100.00% | - | - |
| Period with return > 15% | 71.20% | 100.00% | - | - |
| Beat % Category | 100.00% | 100.00% | - | - |
| Beat % Benchmark | 71.40% | 0.00% | - | - |
Trailing Returns
Point-to-point returns of HDFC Pharma And Healthcare Fund Direct-Growth vs category average for YTD, 1M, 6M, 1Y, 3Y, 5Y and 10Y periods — with category rank and total funds count.
0%
20%
40%
17.5%
9.8%
13.3%
YTD
-8.3%
-8.3%
-4.9%
1 M
12.7%
9.4%
14.4%
6 M
16.6%
7.3%
14.4%
1 Y
27.7%
19.9%
45.4%
3 Y
14.8%
13.7%
5 Y
14.4%
9.1%
10 Y
Fund
Equity: Sectoral-Pharma
BSE Healthcare Total Return Index
| Name | YTD | 1 M | 6 M | 1 Y | 3 Y | 5 Y | 10 Y | Since Inception |
|---|---|---|---|---|---|---|---|---|
| Fund | 17.47% | -8.34% | 12.71% | 16.56% | 27.69% | - | - | 27.11% |
| Equity: Sectoral-Pharma | 9.83% | -8.31% | 9.40% | 7.30% | 19.91% | 14.81% | 14.40% | - |
| BSE Healthcare Total Return Index | 13.30% | -4.88% | 14.39% | 14.37% | 45.35% | 13.73% | 9.09% | - |
| Rank in category | 2 | 12 | 6 | 1 | 1 | - | - | - |
| Funds in category | 22 | 24 | 23 | 21 | 12 | 8 | 4 | - |
Period Returns
Calendar-year, quarterly and monthly return history of HDFC Pharma And Healthcare Fund Direct-Growth. Toggle between bar chart and table view to analyse periodic performance trends.
Historical Performance
Track NAV movement and cumulative returns of HDFC Pharma And Healthcare Fund Direct-Growth across 1M, 6M, 1Y, 3Y, 5Y and since-inception periods. Compare SIP and lumpsum growth over time.
Compare performance with respect toAdd benchmark
Add benchmark
Frequently Asked Questions
What are the 1-year returns of HDFC Pharma And Healthcare Fund Direct-Growth?
HDFC Pharma And Healthcare Fund Direct-Growth has delivered a 1-year return of 16.56% as of 21 Oct 2026. During the same period, its benchmark BSE Healthcare Total Return Index returned 14.37%. The fund has outperformed its benchmark over this period.
What are the 3-year returns of HDFC Pharma And Healthcare Fund Direct-Growth?
HDFC Pharma And Healthcare Fund Direct-Growth has delivered a 3-year CAGR of 27.69% as of 21 Oct 2026. Its benchmark BSE Healthcare Total Return Index returned 45.35% CAGR over the same period. CAGR (Compounded Annual Growth Rate) is the right way to evaluate multi-year mutual fund performance as it smooths out year-to-year volatility.
What are the 5-year returns of HDFC Pharma And Healthcare Fund Direct-Growth?
The 5-year CAGR for HDFC Pharma And Healthcare Fund Direct-Growth is shown in the Trailing Returns section above.
What are the returns of HDFC Pharma And Healthcare Fund Direct-Growth since inception?
Since its launch on 10 Oct 2023, HDFC Pharma And Healthcare Fund Direct-Growth has delivered a CAGR of 27.11%. Since-inception returns reflect the fund's full history and give the most complete picture of long-term performance.
How has HDFC Pharma And Healthcare Fund Direct-Growth performed vs its category over the long term?
Over the long term, HDFC Pharma And Healthcare Fund Direct-Growth has ranked 1 out of 12 funds in the Equity: Sectoral-Pharma category on a 3-year basis, and - on a 5-year basis. Category rank is one of several factors to consider alongside risk metrics and rolling return consistency when evaluating a fund.
What is the Sharpe ratio of HDFC Pharma And Healthcare Fund Direct-Growth?
The Sharpe ratio of HDFC Pharma And Healthcare Fund Direct-Growth is shown in the Alpha, Beta & Sharpe section above.
What is the alpha of HDFC Pharma And Healthcare Fund Direct-Growth?
The alpha of HDFC Pharma And Healthcare Fund Direct-Growth is shown in the Alpha, Beta & Sharpe section above.
What is the beta of HDFC Pharma And Healthcare Fund Direct-Growth?
The beta of HDFC Pharma And Healthcare Fund Direct-Growth is shown in the Alpha, Beta & Sharpe section above.
What are the rolling returns of HDFC Pharma And Healthcare Fund Direct-Growth?
The average 1-year and 3-year rolling returns of HDFC Pharma And Healthcare Fund Direct-Growth is 24.74% and 27.84% respectively. Rolling returns show the fund's annualized return across every possible 1-year and 3-year investment window, making them a far more reliable measure of consistency than point-to-point returns, which depend heavily on the start and end date chosen.